Not that it matters now, but the August 2023 plan didn't collect any CP data until the 2030s. It was purely focused on anticancer activity until Phase 3.
You are right that AML will be running behind the CPACS trial and that it won't treat the first patient until H1 2025.
General Comments / Chat, page-11426
-
-
- There are more pages in this discussion • 456 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.59 |
Change
0.010(0.63%) |
Mkt cap ! $270.9M |
Open | High | Low | Value | Volume |
$1.60 | $1.60 | $1.56 | $168.3K | 106.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 51 | $1.56 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.60 | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 54981 | 1.550 |
1 | 700 | 1.520 |
1 | 2750 | 1.510 |
3 | 7984 | 1.505 |
5 | 17550 | 1.500 |
Price($) | Vol. | No. |
---|---|---|
1.600 | 20000 | 1 |
1.620 | 2000 | 1 |
1.685 | 5000 | 1 |
1.690 | 6570 | 3 |
1.695 | 7731 | 1 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |